A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. AE Jerse, J Yu, BD Tall, JB Kaper Proceedings of the National Academy of Sciences 87 (20), 7839-7843, 1990 | 1433 | 1990 |
Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. KG Jarvis, JA Giron, AE Jerse, TK McDaniel, MS Donnenberg, JB Kaper Proceedings of the National Academy of Sciences 92 (17), 7996-8000, 1995 | 784 | 1995 |
Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice AE Jerse Infection and immunity 67 (11), 5699-5708, 1999 | 269 | 1999 |
Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC‐MtrD‐MtrE Efflux pump system confer different levels of antimicrobial resistance and … DM Warner, WM Shafer, AE Jerse Molecular microbiology 70 (2), 462-478, 2008 | 248 | 2008 |
Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. AE Jerse, MS Cohen, PM Drown, LG Whicker, SF Isbey, HS Seifert, ... The Journal of experimental medicine 179 (3), 911-920, 1994 | 246 | 1994 |
A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection AE Jerse, ND Sharma, AN Simms, ET Crow, LA Snyder, WM Shafer Infection and immunity 71 (10), 5576-5582, 2003 | 242 | 2003 |
Human Experimentation with Neisseria gonorrhoeae: Rationale, Methods, and Implications for the Biology of Infection and Vaccine Development MS Cohen, JG Cannon, AE Jerse, LM Charniga, SF Isbey, LG Whicker Journal of infectious diseases 169 (3), 532-537, 1994 | 195 | 1994 |
Neisseria gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development PA Rice, WM Shafer, S Ram, AE Jerse Annual review of microbiology 71 (1), 665-686, 2017 | 190 | 2017 |
Virulence Factors in Shiga-like Toxin-Producing Escherichia coliIsolated from Humans and Cattle TJ Barrett, JB Kaper, AE Jerse, IK Wachsmuth Journal of Infectious Diseases 165 (5), 979-980, 1992 | 180 | 1992 |
Estradiol-Treated Female Mice as Surrogate Hosts for Neisseria gonorrhoeae Genital Tract Infections AE Jerse, H Wu, M Packiam, RA Vonck, AA Begum, LE Garvin Frontiers in microbiology 2, 107, 2011 | 176 | 2011 |
Regulation of the MtrC-MtrD-MtrE Efflux-Pump System Modulates the In Vivo Fitness of Neisseria gonorrhoeae DM Warner, JP Folster, WM Shafer, AE Jerse Journal of Infectious Diseases 196 (12), 1804-1812, 2007 | 153 | 2007 |
The global roadmap for advancing development of vaccines against sexually transmitted infections: update and next steps SL Gottlieb, CD Deal, B Giersing, H Rees, G Bolan, C Johnston, P Timms, ... Vaccine 34 (26), 2939-2947, 2016 | 144 | 2016 |
Vaccines against gonorrhea: current status and future challenges AE Jerse, MC Bash, MW Russell Vaccine 32 (14), 1579-1587, 2014 | 138 | 2014 |
Experimental Gonococcal Infection in Male Volunteers: Cumulative Experience with Neisseria gonorrhoeae Strains FA1090 and MS11mkC MM Hobbs, PF Sparling, MS Cohen, WM Shafer, CD Deal, AE Jerse Frontiers in microbiology 2, 123, 2011 | 136 | 2011 |
Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models L Zeitlin, TE Hoen, SL Achilles, TA Hegarty, AE Jerse, JW Kreider, ... Sexually transmitted diseases 28 (7), 417-423, 2001 | 118 | 2001 |
Inhibition of Neisseria gonorrhoeae by Lactobacillus Species That Are Commonly Isolated from the Female Genital Tract DC St. Amant, IE Valentin-Bon, AE Jerse Infection and immunity 70 (12), 7169-7171, 2002 | 117 | 2002 |
Characterization of Interactions of Enteropathogenic Escherichia coli 0127:H6 with Mammalian Cells In Vitro CL Francis, AE Jerse, JB Kaper, S Falkow Journal of Infectious Diseases 164 (4), 693-703, 1991 | 115 | 1991 |
Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection J Ngampasutadol, S Ram, AM Blom, H Jarva, AE Jerse, E Lien, J Goguen, ... Proceedings of the National Academy of Sciences 102 (47), 17142-17147, 2005 | 107 | 2005 |
Vaccines for gonorrhea: can we rise to the challenge? W Zhu, CJ Chen, CE Thomas, JE Anderson, AE Jerse, PF Sparling Frontiers in microbiology 2, 124, 2011 | 104 | 2011 |
Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations AN Kunz, AA Begum, H Wu, JA D'Ambrozio, JM Robinson, WM Shafer, ... The Journal of infectious diseases 205 (12), 1821-1829, 2012 | 101 | 2012 |